NCT01406223View on ClinicalTrials.gov

Mechanistic Evaluations of Pre-Cessation Therapies for Smoking Cessation

PHASE3CompletedINTERVENTIONAL
Enrollment

282

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

June 30, 2014

Conditions
Nicotine Dependence
Interventions
DRUG

Varenicline

DRUG

Bupropion

DRUG

Nicotine patches

OTHER

Placebo varenicline

OTHER

Placebo bupropion

OTHER

Placebo patch

Trial Locations (2)

27609

Duke Center for Nicotine and Smoking Cessation Research, Raleigh

27705

Duke Center for Nicotine and Smoking Cessation Research, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Duke University

OTHER